Angioedema With Normal Complement Studies: What Do We Know?

Constance H Katelaris, Anete S Grumach, Konrad Bork

The journal of allergy and clinical immunology. In practice 2023 Aug

filter terms:

Angioedema is generally readily recognizable clinically and is characterized by localized nonpitting edema involving subcutaneous, submucosal, or deep dermal tissue caused by increased vascular permeability and extravasation of intravascular fluid. It can occur via a variety of mechanisms. A number of clinical conditions (masqueraders) are occasionally mistaken for angioedema. Clinical classification of the various angioedema forms begins with noting the presence or absence of concurrent urticaria or wheals. Pathogenesis can be considered through two broad categories: mast cell-mediated with release of vasoactive mediators causing angioedema usually associated with urticaria or in the context of an anaphylactic reaction; and bradykinin (BK)-driven, in which increased vascular permeability is mediated by BK. BK-mediated angioedema does not occur with urticaria, nor does it respond to antiallergic medications. The various forms of hereditary angioedema are included in this category, requiring specific tests of C4 and C1 inhibitor level and function to confirm the diagnosis. Angiotensin converting enzyme inhibitors, which impair the degradation of BK, account for up to a third of all patients with angioedema presenting to the emergency department. Finally, angioedema may occur by yet unknown mechanisms; under this circumstance, it is difficult to manage. Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.

Citation

Constance H Katelaris, Anete S Grumach, Konrad Bork. Angioedema With Normal Complement Studies: What Do We Know? The journal of allergy and clinical immunology. In practice. 2023 Aug;11(8):2309-2314